FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Info Collection on Device Reclassification Petitions

Federal Register notice: FDA seeks comments on an information collection extension entitled Reclassification Petitions for Medical Devices 21 CFR Par...

latest-news-card-1
Medical Devices

Philips Recalls Sense XL Torso MRI Coils

Philips North America recalls its Sense XL Torso (1.5T and 3.0T) MRI coils to update use instructions due to a potential issue where the coil heats up...

latest-news-card-1
Human Drugs

Groups Want Changes in Drug Labeling Guidance

Two drug company associations recommend changes to an FDA draft guidance on the content and format of labeling statements of ingredients in NDAs and A...

latest-news-card-1
Medical Devices

Magellan Guilty Plea Over Misbranded Devices

Magellan Diagnostics pleads guilty in federal court to criminal charges arising from its concealment of a device malfunction that produced inaccuratel...

Human Drugs

Carvykti Improves Survival in Phase 3 Trial: J&J

J&J touts positive overall survival results of its Carvykti in a Phase 3 trial in patients with relapsed or lenalidomide-refractory multiple myeloma a...

latest-news-card-1
Human Drugs

Checkpoint Resubmits Cosibelimab BLA

Checkpoint Therapeutics says it has completed the resubmission of a BLA for its cosibelimab cancer treatment.

latest-news-card-1
Human Drugs

FDA OKs Pyzchiva as Stelara Biosimilar

FDA approves Samsung Bioepis Pyzchiva as an interchangeable biosimilar for Janssens Stelara.

latest-news-card-1
Human Drugs

FDA OKs Genentechs Vabysmo Syringe

FDA approves a Genentech Vabysmo prefilled syringe to treat three retinal disorders with the same medicine as Vabysmo vials.

latest-news-card-1
Human Drugs

FDA Drops Interchangeability Switching Studies

Venable attorney Robert Schwartz says an updated FDA guidance with alternatives to switching studies for demonstrating biosimilar interchangeability i...

latest-news-card-1
Human Drugs

CGMP Violations in Sun Pharmaceutical Inspection

FDA warns Indias Sun Pharmaceutical Industries about repeat CGMP violations at one drug manufacturing facility and in other company facilities.